• BevCanna Enterprises’ TRACE line of natural alkaline and mineral-infused spring waters have been named as the official water supplier for Vancouver’s 2022 Canadian E-Prix event
• TRACE Natural Alkaline Spring Water, which originates from BevCanna’s wholly owned natural spring water aquifer in British Columbia, are renowned for their optimal mineral content and eco-friendly packaging
• BevCanna will launch a unique, commemorative package for its signature water brand in the run-up to the Vancouver E-Prix
• The event will serve to further propagate the TRACE brand name, with the company already named as the official water supplier to British Columbia’s firefighters

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), a diversified health and wellness beverage and natural products company developing and manufacturing a range of alkaline, plant-based and cannabinoid beverages and supplements for both in-house brands and white-label clients, has announced that its market-leading TRACE line of natural alkaline spring waters will be the official water supplier of the Canadian E-Prix/2022 Vancouver E-Prix event, which includes the highly anticipated Formula E electric car race (https://ibn.fm/RcDMB). Taking place between June 30 to July 2, 2022, the three-day Canadian E-Fest will welcome the ABB FIA Formula E World Championship to the streets of Vancouver for the first time. The festival will play host to a fan village, feature concerts by two top Canadian musical artists, and to cap it off, will showcase the Formula E electric car race, which will be held on July 2 in Vancouver’s False Creek. BevCanna Enterprises’ TRACE Natural Alkaline and Mineralized Spring Water brand originates in Canada’s Rocky Mountain range, featuring some of the world’s purest water sources. Drawn at the source from a natural aquifer in British Columbia’s Okanagan region, TRACE’s natural alkaline spring water has naturally occurring trace minerals and a 7.7pH, while the mineralized spring waters are infused with fulvic and humic minerals – naturally derived elements which come from decomposed organic matter, and which have been shown to provide benefits to health and the body including boosting the immune system, decreasing inflammation, improving brain function, reducing fatigue, and aiding iron absorption, all while boosting the pH to 8.5pH. Moreover, the alkaline water provides additional benefits to the consumer as compared to most tap and conventional bottled water, including the increased presence of hydroxyl ions, increased hydration, improved bone health, healthier skin and decreased gastrointestinal symptoms (https://ibn.fm/Im17a). The upcoming Vancouver E-Prix event will feature TRACE’s product portfolio of natural and mineralized alkaline spring waters, including the brand’s unique and proprietary mineralized black water. In keeping with the racing festival’s focus on sustainability, TRACE’s products will be packaged in 100% recyclable aluminum cans with TRACE also operating as the Canadian E-Fest’s official recycling partner. To further commemorate the event, TRACE will be launching a special edition Canadian E-Fest branded version of its distinctive aluminum can packaging, featuring a custom Formula E Race logo, with the commemorative can available for sale at leading Canadian retailers in the run-up to the event. “We’re pleased to have been chosen as the official Water Supplier for this unique event,” said Melise Panetta, President of BevCanna. “The Canadian E-Fest event, and especially the Formula E race, will be a highlight of Summer 2022 and we’re thrilled to be a part of it. The Canadian E-Fest’s commitment to sustainability and recycling is significant and we believe it is important to partner on this shared vision.” For more information, visit the company’s website at www.BevCanna.com. NOTE TO INVESTORS: The latest news and updates relating to BVNNF are available in the company’s newsroom at http://ibn.fm/BVNNF

• The Bitcoin Lighting Network, for efficient bitcoin transactions, is seeing more players who are interested in providing an offering that is low fee and instantaneous
• It is estimated that 700 million users will be utilizing the Lightning Network by 2030
• LQwD’s proprietary platform-as-a-service offering is designed to simplify users’ access to the Lightning Network and make it far easier to complete faster, more affordable transactions
• While LQwD remains the only public company focused on Bitcoin Lightning Network, a growing number of companies and entities are becoming interested in leveraging the network’s opportunities

The Lightning Network is becoming a popular way for companies to incorporate Bitcoin into their payment infrastructure. The Lightning Network, as a concept, was first proposed to the public by Joseph Poon and Thaddeus Dryja in 2015 – but has been under development since that time. The Lightning Network is a second-layer technology applied to bitcoin using micropayment channels to essentially scale the blockchain’s capability and conduct transactions quickly and efficiently. With the Lightning Network, users of Bitcoin can say goodbye to the frustrating “mainchain” experience they often deal with when trying to send, receive, or purchase using bitcoin as a payment method. Taking the payments off the main blockchain has allowed for transaction costs to be lower and more efficient overall. As more countries move toward the acceptance of bitcoin as a legal tender (like El Salvador), companies are being required to find ways to accept these payments, and the Lightning Network makes it possible for it to be done without the high number of fees required. This has attracted the interest of several companies and entities ready to leverage the network to both support its growth and their own development. One such company, and so far, the only publicly listed company working with the Lightning Network, is LQwD FinTech (TSX.V: LQWD) (OTCQB: LQWDF), a fintech firm focused on creating enterprise-grade infrastructure to drive bitcoin adoption. The company intends to grow the Lightning Network through its proprietary platform as a service (PaaS) lqwd.tech, launched on November 17. The platform was designed to facilitate and simplify access to the Lightning Network, as well as allow users to more easily send payments instantly, securely, and inexpensively anywhere in the world. Upon the platform’s launch, the company deployed a part of its own Bitcoin holdings to procure additional nodes and provide liquidity for the platform. Aiming to empower institutions, businesses, and investors working with the Lightning Network, lqwd.tech was designed to be scalable and adaptive to the fast-paced growth of the Network, allowing for millions of Bitcoin transactions in seconds. The company expects that the Lightning Network will be a force for change globally and become the global monetary exchange of the future. Another company making great strides at incorporating the Lightning Network into its overall infrastructure is CardCoins. CardCoins is a company that allows users to take gift cards and exchange them for Bitcoin. By doing this on the Lightning Network, CardCoins is making transactions simpler and more cost-efficient. As the Lightning Network is being incorporated into various industries, products are being adapted for easier use. One such product is LNURLVend, a device created by developer Ben Arc which essentially works as an offline bitcoin vending machine. The device allows users to buy drinks or sweet treats from a vending machine, using their bitcoin and the Lightning Network (https://ibn.fm/hrZ6h). The operation of it is simple – choose what you want, scan the QR with a Lightning-compatible wallet and then pay, using your PIN for an additional layer of security. “With that, you get a vending machine without an internet connection, and that works with Bitcoin’s Lightning Network, fully functional,” Arc explained his concept. To add perspective on the Lightning Network, recent research from Arcane Research indicated that the number of users on the network is likely to reach 700 million by 2030. Key factors considered by the report include remittance, gaming, streaming, and monetary transaction needs (https://ibn.fm/a76wu). The report also explained how in 2021, wallet use has increased by 20% a month, with the largest numbers coming from regular daily use as opposed to online services. For more information, visit the company’s website at www.LQwDFinTech.com. NOTE TO INVESTORS: The latest news and updates relating to LQWDF are available in the company’s newsroom at https://ibn.fm/LQWDF

• Mineral property exploration company StraightUp Resources is building a portfolio of gold and silver mining options in Canada, the United States and Peru
• The company has been particularly focused thus far on its options in Ontario, Canada’s prolific Red Lake mining district, where airborne surveys and follow up ground investigation have been completed to analyze site potential
• While gold’s market performance has been lackluster in recent months due to investor skittishness, many analysts predict that inflationary pressures will create a resurgence of gold-hungry activity
• Silver-bullish investors are likewise predicting the metals’ prospects will improve in coming years as a result of a renewed emphasis on green energy

The global COVID pandemic will soon enter its third year. Amid predictions that infections and hospitalizations will drop far enough that the health crisis could lose its pandemic status in 2022 (https://ibn.fm/JEx89), gold-bullish analysts are also anticipating that a huge jump in monetary printing during the past year and a half will continue to drive inflation that could lead the United States into a gold-hungry bear market. “The Fed effectively doubled the US monetary base in just over a year-and-a-half, wildly unprecedented. That deluge added up to an insane $4,492b of new dollars injected into the system in that span,” Adam Hamilton recently wrote for Seeking Alpha. “Gold has spent the past-half year grinding sideways on balance because apathetic investors are missing in action. … Several major gold-bullish catalysts are coalescing around a common linchpin of raging inflation. As this comes to a head, investors’ vexing gold apathy will be shattered. Facing a situation never before seen in market history, they will likely flock back to gold with a vengeance,” he concluded (https://ibn.fm/ueTKn). Silver outperformed gold among investors in 2020, but lost its momentum in 2021. However, some silver-bullish forces predict that a renewed emphasis on green energy sectors expected during the coming years will improve the metal’s appeal. Maria Smirnova of Sprott Asset Management stated in a recent webinar that by 2030 demand from the green energy space, specifically solar panels alone, is estimated to grow by 250 million to 400 million ounces, representing 25 to 40 percent of the entire silver market, The Investing News Network reported (https://ibn.fm/96QSt). “I cannot for the life of me imagine a world in which we can conjure up an extra 300 million ounces of silver just like that. It will be hard work,” Smirnova said in the webinar. “So from that perspective, and again, overlaying the investment demand side of things, we’re quite bullish on silver.” Precious metals explorer and mining property acquisition enterprise StraightUp Resources (CSE: ST) (OTCQB: STUPF) has been increasing its options for gold and silver-potential sites in line with its expectations of the metals’ ongoing potential, building a portfolio during the pandemic era that currently includes the West Cat gold and silver mine in the state of Nevada (United States), options for five gold properties in Ontario, Canada’s well-known greenstone belt (https://ibn.fm/vrjGo), and the potential acquisition of the a historically productive silver mine and processing plant in the Lima region of Peru through a right of exclusivity agreement (“ROE”) with Premier Silver Corp. (https://ibn.fm/1c86l). The eastern Canada properties have commanded the lion’s share of the company’s attention thus far, and interpretation of recent high-resolution heli-borne magnetic surveys (“MAGs”) and the subsequent ground investigation efforts have confirmed “multiple areas of high merit and potential mineralization” (https://ibn.fm/fIGHM) on one of the sites, the Ferdinand Gold Project, which consists of 17 contiguous mining claims covering 7,143 hectares (17,651 acres) at the eastern end of Ontario’s Red Lake mining district. “There is not one Ontario Geological Survey registered drill hole on the entire property,” the company states, adding that government-sponsored magnetic surveys of the site have nonetheless determined that there is a folded stratigraphy along possibly D2 structures, an important geographical feature for gold-bearing hydrothermal fluids and traps (https://ibn.fm/q3kU7). Another of the Ontario sites, the 1,944-hectare (4,803.7-acre) Bear Head Gold Project, is considered particularly significant because historical drilling there in 1989 recorded gold at 11.09 g/t Au over 1.79m, 3.98 g/t Au over 2.3m and 3.08 g/t Au over 2.5m, but the results have not been followed up on by additional drilling (https://ibn.fm/8gkWt). For more information, visit the company’s website at www.StraightUpResources.com. NOTE TO INVESTORS: The latest news and updates relating to STUPF are available in the company’s newsroom at https://ibn.fm/STUPF

• RYAH recently released report highlighting medical cannabis treatment for cancer and adverse effects of cancer treatment
• Data from 80,000 sessions logged between January 1, 2018 and November 15, 2021 tracked conditions including anxiety, cachexia, fatigue, pain, nausea, and stress
• 62% of patients reported a moderate experience using cannabis to treat cancer-related conditions
• RYAH supports cancer research and treatment with IoT product ecosystem comprised of volume-control devices, medicine-carrying components, mobile applications

RYAH Group (CSE: RYAH), the leader in volume-control technology for plant-based medicine, recently released a medical cannabis report on cancer and the adverse effects of cancer treatment (https://ibn.fm/Es52b). Data from 80,000 sessions logged between January 1, 2018, and November 15, 2021, tracked conditions that occur with a cancer diagnosis or are associated with cancer treatments. Conditions highlighted in the report included anxiety, cachexia, fatigue, pain, nausea, and stress. According to the report, patients preferred Sativa and Sativa-dominant strains for anxiety and stress, with an equal split of Indica-dominant and Sativa-dominant strains for pain. Sixty-two percent of patients reported a moderate experience with cannabis, suggesting that respondents found relief from one or more of these symptoms. While there seem to be rising rates of cancer patients exploring cannabis use, according to the report, the evidence collected to date does not currently support this application due in part to a lack of robust, randomized control trials. RYAH’s technology supports cannabis research for the treatment of cancer with innovative technology that collects, analyzes, and leverages objective data on therapeutic plant usage. By using the company’s smart devices and integrated AI-powered platform, patients and doctors can stay on top of prescription treatments in a safe, secure, and seamless way. RYAH’s current portfolio integrates IoT devices, medicine-carrying components, and mobile applications to create an ecosystem that enables practitioners and patients to administer treatments, control volume, collect data, and produce analytics that can power insights for research purposes. Current products in the pipeline include a Smart Dry-Herb Dose-Measuring Inhaler in the commercial stage, a Smart Transdermal Patch in the production stage, and a Smart Liquid Dispensing Pen in the prototype stage. The RYAH Smart Inhaler is a medically certified device under ISO 13485 standards. The device provides consistent and predictable results by allowing users to control and track medicine administration. When connected to the RYAH Health App, practitioners can monitor statistics, temperature presets, and volume amounts to customize treatment and improve results. RYAH’s alternative treatment protocol – the RYAH Smart Transdermal Patch – features a lightweight, reusable, mobile-controlled patch that can be applied for site-specific therapies and controlled with a mobile application to allow scheduled and on-demand “boosting” if required. RYAH’s Smart Pen will leverage a customized multi-component treatment approach with an app-controlled liquid dispenser that allows multiple medicine components to be combined to produce an “entourage effect.” Using cartridges that contain CBD, THC, other cannabis isolates, and vitamins, the Smart Pen controls volume with a built-in mechanism that draws data from a mobile application. RYAH’s doctor collaboration platform, RYAH MD, allows doctors to create digital recommendations for patients and track patient usage for all RYAH IoT devices. RYAH MD will allow doctors to have more oversight on patient use of cannabis products, enabling them to develop highly customized regimens. RYAH holds a unique position at the intersection of the $100.3 billion medical plant market (https://ibn.fm/GVHHK) and IoT and Data Intelligence sectors. As the leading data technology company in plant-based medicine, RYAH is committed to helping researchers produce valuable insights that transform patient care with the power of big data and artificial intelligence. For more information, visit the company’s website at www.RYAHGroup.com. NOTE TO INVESTORS: The latest news and updates relating to RYAH are available in the company’s newsroom at https://ibn.fm/RYAH

• Mydecine’s and CMPS’ stocks have been grossly undervalued largely due to a lack of understanding of the psychedelic space
• The situation presents a unique opportunity for investment, as Roth Capital Partners issued a $3 buy rating for 2022
• Mydecine has put systems and infrastructure in place to bank on the growing PTSD treatment, smoking cessation, and the health and wellness apps market, in its drive to increase value for its shareholders

There has been a huge misunderstanding of the psychedelic space and the potential that this industry has, specifically regarding the treatment of Post-Traumatic Stress Disorder (“PTSD”) and smoking cessation. This has led to undervalued equities for key players within this space including, but not limited to Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) and Compass Pathways (NASDAQ: CMPS). In October 2021, CMPS released findings from its open-label study of psilocybin therapy to treat depression among cancer patients. Of note was that with a single administration of the COMP360 psilocybin therapy, over half of the patients in the study achieved remission in depression systems, sustained over eight weeks (https://ibn.fm/jLei7). Soon after this important announcement, the value of CMPS stock fell by almost 30%. The drop was attributed to two key aspects. Firstly, traders, as opposed to doctors, read the research and reacted to it negatively. CMPS’ research posted a 50% success rate in treatment-resistant, clinically depressed patients. These patients had to deal with five different clinical treatments with a 0% success rate before achieving a 50% success rate with CMPS. Secondly, the audience lacked the understanding of data and science, prompting them to sell. “People who really did not grasp the significance of the data, they decided to sell,” noted Elemer Piros, an analyst at Roth Capital Partners. CMPS’s challenges also affect Mydecine, an enterprise working towards transforming the treatment of mental health disorders and addiction. Its use of novel psychedelic and non—psychedelic molecules for medical use shows great promise within the industry. Still, the stigma and misunderstanding of the products and what they can achieve comes. As it stands, Mydecine’s stock is trading at $0.16. However, it is one of the few stocks projected to grow tremendously in value in 2022. For one, Mydecine is well-positioned within PTSD treatment, smoking cessation, and the health and wellness apps market, which are valued at a combined $50 billion. It is projected that by 2026, the global smoking cessation market will be valued at $63.99 billion, representing a CAGR of 16.9% over the forecast period (2018-2026) (https://ibn.fm/kOhy2). It is also estimated that the market for psychedelic therapeutics will be valued at $69 billion by 2025, representing a CAGR of 8.2%, indicating the clear growing interest in psychedelic therapeutic drugs (https://ibn.fm/cOxTm). The PTSD market is currently valued at $990 million, with tremendous potential for growth (https://ibn.fm/oOyiD). Tapping into these markets with its technology shows Mydecine’s incredible value. Given its achievements so far and the plans it has already in place, Mydecine is grossly undervalued. This, in turn, presents a huge investment opportunity, a fact that is backed by Roth Capital Partners’ $3 buy rating issue (https://ibn.fm/WEdMU). Mydecine has partnered with the Johns Hopkins University (“JHU”) for its phase 2/3 smoking cessation clinical trial set to launch in early 2022 in what promises to be the company’s most ambitious clinical study yet (https://ibn.fm/7zM0Q). In addition to their seamless phase 2/3 design, Mydecine plans to supply their lead drug candidate, MYCO-001, for Dr. Matthew Johnson’s NIDA grant-funded multi-site smoking cessation study (https://nnw.fm/fomME). With safety and efficacy data from both studies, Mydecine is well positioned to possibly bring a smoking cessation treatment to market as early as 2024. The company has filed a technology patent that allows for the creation of formulations that make use of nano-emulsion technology to enhance, stabilize and make repeatable properties of ingredients from traditional medicine. CEO Josh Bartch stated in a recent press release (https://ibn.fm/07SrX), “The compatibility of these formulas as patent-protected ingredients has Mydecine excited to develop a wide variety of licensing opportunities.” Mydecine’s most recent patent application covers a family of psilocin analogs, psilocybin’s active metabolite, with solutions to directly address precision in delivery control and shelf stabilization (https://ibn.fm/Dwax1). The company believes these improvements will enable safer more effective treatments and ultimately lead to acceptance and adoption of psychedelic medicine. All these moves indicate a company committed to achieving its goals and building value for its shareholders. Moreover, systems and infrastructure so far guarantee the company’s growth in the 2022 calendar year, making it a grossly undervalued company and a viable investment that promises significant returns. For more information, visit the company’s website at www.Mydecine.com. NOTE TO INVESTORS: The latest news and updates relating to MYCOF are available in the company’s newsroom at https://ibn.fm/MYCOF

• The hurdles and obstacles that hydrogen manufacturing still must contend with provide companies like FuelPositive with the ability to help facilitate the zero-emission goal by providing technology to produce and utilize green ammonia affordably
• The use of green ammonia not only helps facilitate the upcoming goal of The Hydrogen Economy but it also provides a more cost-efficient and stable option
• The global green ammonia market was valued at $9.52 million in 2019 and is expected to grow at a CAGR of 53.9% over the 2020 to 2027 forecast period

The consensus at the recent UN COP26 Climate Change Conference in November 2021 was to attain carbon neutrality by 2050. Despite the number of hurdles and obstacles ahead, it was agreed that the stability of the world hangs in the balance of executing this goal. In the past, alternative renewable energy sources have been offered as a solution to the current state of the environment. The problem with alternatives like wind or solar energy is that the medium needed to keep them going is not always available. The “green” solution that has surfaced from the Climate Change Conference is what is being referred to as green hydrogen (https://ibn.fm/5uP7o). Traditional methods of producing hydrogen rely on fossil fuels, creating what has been labeled as “grey hydrogen.” This method of producing grey hydrogen results in extensive pollution in the form of greenhouse gases. However, when fossil fuels are traded for renewable resources, hydrogen can be created without producing carbon emissions. Regarding the future of green hydrogen, Columbia University’s energy policy expert Anne-Sophie Corbeau stated “Any forecast at this stage is highly uncertain, but it’s fair to say that there is a trend showing lower fossil fuel demand and higher hydrogen demand.” Canadian-based clean energy solutions innovator FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF) recognizes the potential that hydrogen has as a fuel source but also sees the potential setbacks that may surface as a result. The Hydrogen Economy, albeit the goal, still has challenges to overcome before it is a truly viable solution to replace fossil fuels and create the carbon-neutral outcome desired. Some of these challenges hydrogen production faces include:

• Requiring energy-intensive, highly polluting production
• Producing a highly-volatile end product
• Needing storage conditions that are kept under extremely high pressure and cryogenic temperatures
• Escaping at room temperature and making structures brittle
• Having a virtually non-existent distribution infrastructure
• Having severe transportation concerns attached

FuelPositive’s proprietary green ammonia production system, on the other hand, provides the solution to these hydrogen problems and more. Green ammonia needs less energy to produce than other methods of NH3 production, but with no carbon emissions. FuelPositive’s green ammonia stores 65% more hydrogen than the highly compressed hydrogen products. Given hydrogen’s current obstacles, the use of green ammonia can circumvent them – providing lower cost from start to finish, easier storage, easier transportation, and the existing ammonia infrastructure can be used. FuelPositive’s green ammonia comes with multiple advantages, such as:

• Eliminates the fertilizer-related carbon emissions in agriculture
• Replaces fossil fuels used for transportation in large engines (like farm equipment, trucks and ships)
• Provides an affordable, convenient, and sustainable supply of hydrogen for fuel cells
• Offers long-term storage of excess electricity for energy grids
• Provides electricity to northern/remote communities
• Facilitates the shift to The Hydrogen Economy
• Produces significant carbon credits as a result of emission reduction
• Reduces the need for massive, highly polluting ammonia production factories and inefficient supply chains

The benefits of green ammonia are becoming widely recognized, and the global market is expanding as a result. According to a MarketWatch research report, the global green ammonia sector was valued at $9.52 million in 2019 and is expected to grow at a CAGR of 53.9% over the 2020 to 2027 forecast period (https://ibn.fm/5jcFK). This is likely to increase as the world moves forward with the elimination of traditional fossil fuels, which are proven bad for the environment, and implements changes to facilitate the goal of carbon-neutrality by 2050. For more information, visit the company’s website at www.FuelPositive.com. NOTE TO INVESTORS: The latest news and updates relating to NHHHF are available in the company’s newsroom at https://ibn.fm/NHHHF

• Ketamine Wellness Centers (“KWC”) has partnered with the Veterans Administration (“VA”) Community Care Networks in Illinois and Minnesota
• KWC will provide veterans with ketamine treatments for depression, chronic pain and PTSD at no out-of-pocket cost at these locations
• Meet Delic was held on November 6 and 7 and became the world’s largest psychedelic wellness event

Delic Holdings (CSE: DELC) (OTCQB: DELCF), a leader in new medicines and treatments for a modern world, has announced its subsidiary, Ketamine Wellness Centers LLC (“KWC”), has entered two new partnerships with the Veteran Administration (“VA”) Community Care Networks of Illinois and Minnesota. KWC, which boasts the nation’s largest chain of psychedelic wellness clinics, will offer ketamine treatments to veterans at no out-of-pocket cost at their locations in Naperville, IL and Burnsville, MN. The program will cover patients who have suffered from post-traumatic stress disorders, major depression, and chronic pain, and who have exhausted all traditional medical treatments. Vancouver-based Delic recently sought to expand its presence within the psychedelic wellness space, entering into a merger agreement with KWC in mid-September. Under the terms of the deal, Delic agreed to acquire KWC’s chain of 10 ketamine infusion clinics, operating across Arizona, Colorado, Florida, Illinois, Minnesota, Nevada, Texas and Washington and merge them with Delic’s existing two ketamine clinics operating under the Ketamine Infusions Centers (“KIC”) (https://ibn.fm/gpJoC). Delic now expects to open 15 additional clinics across the country over the coming 18 months, in a bid to further its goal of expanding access to millions who can benefit from psychedelic treatment for a variety of mental health conditions and cementing its position as the leader and largest provider of psychedelic wellness in the U.S. Regarding the partnership between KWC and the VA, Delic co-founder Matt Stang said: “This partnership between KWC and the VA Community Care Network is a true game changer when it comes to the health and wellness of our veterans. They face steep challenges when returning home, especially related to their mental and physical health, including PTSD, depression, and pain. Now they can seek the treatment they need without worrying about whether they can afford it. These brave men and women have sacrificed so much to protect this country and we are honored to support them.” Meet Delic was held on November 6 and 7 and sold out, becoming the world’s largest psychedelic wellness and business conference with over 2,500 attendees from around the world, more than 60 speakers, and 20 hours of programming. Headliners included former NBA star Lamar Odom, who was joined by director Zappy Zapolin and shared his story of addiction and recovery through ketamine treatments, and Duncan Trussell, the actor and comedian who hosted a live taping of his popular Family Hour podcast with author Aubrey Marcus, Vince Kadlubek, founder of Meow Wolf, and actor Johnny Pemberton. “We’re incredibly humbled and unbelievably inspired by the number of people who came out to Meet Delic and joined the conversation on the power of psychedelics to heal and to remove the stigmas surrounding them,” said Jackee Stang, co-founder of Delic. “The world and our minds have evolved, and so should our medicines. We’re already looking forward to 2022 and how we can continue to show the world the latest in proven health and wellness benefits of psychedelics.” Meet Delic 2022 will be held on November 4 and 5 in Las Vegas and tickets are on sale now. For more information, visit the company’s website at www.DelicCorp.com and the Meet Delic conference website at www.MeetDelic.com. NOTE TO INVESTORS: The latest news and updates relating to DELCF are available in the company’s newsroom at https://ibn.fm/DELCF

• Cardiovascular diseases are the leading cause of death worldwide and arterial stiffness serves as a significant marker of related conditions, including hypertension (high blood pressure)
• The company’s studies earlier this year indicated the potential of DehydraTECH to improve CBD’s ability to reduce high blood pressure in a rapid and sustainable manner that exceeds the ability of a generic CBD formulation
• Arterial stiffness is a noted indicator of diseases such as heart, kidney and pancreas organ ailments that increase mortality with age, therefore the ability to reduce arterial stiffness may have implications for improving human wellness and longevity
• HYPER-H21-2 results evidence DehydraTECH-CBD reduces arterial stiffness

Lexaria Bioscience (NASDAQ: LEXX), an innovator in how drugs are utilized by the human body, is reporting newly found benefits from cannabidiol (“CBD”) enhanced by Lexaria’s patented DehydraTECH(TM) technology. The company’s Dec. 8 news release notes that DehydraTECH-formulated CBD was found to reduce arterial stiffness in mild-to-moderate hypertension (high blood pressure) patients volunteering in Lexaria’s HYPER-H21-2 human clinical study (https://ibn.fm/MJ0Xc). The company believes the findings may have a potential impact on efforts to treat not only high blood pressure, but other cardiovascular diseases and other ailments in which blood vessel stiffness is believed to play a significant role. “Reducing arterial stiffness in Lexaria’s recent hypertension study after only a single day of dosing with our DehydraTECH-CBD is a major discovery,” Lexaria President John Docherty stated in the news release. “We know that increased arterial stiffness is correlated with many serious and life-threatening diseases affecting people worldwide, and we are optimistic that our latest findings could have future widespread implications for promotion of improved human health and wellness.” Lexaria’s examination of DehydraTECH-CBD’s effects on arterial stiffness follows its initial findings between July (https://ibn.fm/rUgQV) and September (https://ibn.fm/0tFtD) that hypertensive volunteers using the company’s processed CBD achieved a marked drop in blood pressure relative to generic CBD controls used as a placebo. DehydraTECH is an enabling technological solution that helps drug substances bypass the digestion-liver filtering cycle that may reduce their effectiveness. DehydraTECH’s platform works with the body to rapidly process drugs into the blood stream before potentially being filtered out by the liver’s enzyme-generating factory. Additional testing by Canada’s premier federally funded research organization, the National Research Council demonstrated DehydraTECH processing and formulation technology does not create a covalently bonded new molecular entity (“NME”) and that each drug tested remained stable and did not undergo change in chemical structure.  These findings are strongly supportive of accelerated regulatory filings such as the 505(b)(2) pathway permitted by the Food and Drug Administration and other international regulators, for more rapid market authorizations of prospective DehydraTECH-enabled, repurposed drugs (https://ibn.fm/YfxNf). Lexaria will follow the HYPER-H21-2 study with two new hypertension studies, HYPER-H21-3 and HYPER-H21-4, a new six-week investigation in which multiple doses of DehydraTECH-CBD are expected to indicate further benefits for treating hypertension and arterial stiffness. Arterial stiffness naturally increases with age and is associated with increased mortality from diseases such as diabetes mellitus and kidney disorders, as well as the cardiovascular diseases that are the leading cause of death worldwide (https://ibn.fm/zizu8). Dr. Vernon V S Bonarjee, the head of the cardiology department at Norway’s Stavanger University Hospital, has noted that measuring arterial stiffness may serve as a predictive indicator for determining treatment for cardiovascular disease, even among otherwise asymptomatic individuals, demonstrating the condition’s significance (https://ibn.fm/siA0F). For more information, visit the company’s website at www.LexariaBioscience.com. NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://ibn.fm/LEXX

• Eat Well’s leadership team has founded, built, and sold a previous multi-hundred-million-dollar plant-based food company
• The company’s vertical integration offers an opportunity to invest in the value chain from seed-to-market, rather than a single brand or segment
• Eat Well’s portfolio of companies are uniquely positioned at the epicenter of grower relationships, supply chains and innovation
• The company’s majority owned subsidiary, Amara Organic Foods, has been named the number-one new release on Amazon for its toddler line
• Eat Well’s portfolio revenue is projected to accelerate from $60 million in 2021 to $100 million in 2022

Eat Well Investment Group (CSE: EWG) (OTC: EWGFF), headquartered in Vancouver, British Columbia, is a publicly traded vertically integrated plant-based foods company combining the best of agribusiness, foodtech, and CPG brands to supply the world with innovative, delicious, and better-for-you foods. The company supplies Beyond Meat, Ingredion, Nestle, General Mills and more. It is on track to generate $60 million in revenue for 2021 and is projecting $100 million in revenue for 2022. Eat Well’s management team has an extensive record of sourcing, financing and building successful companies across a broad range of industries and maintains a current investment mandate on the health and wellness industry. The team has financed and invested in early-stage venture companies for more than 25 years, resulting in the ability to construct a portfolio of opportunistic investments intended to generate superior risk-adjusted returns. Eat Well’s strategic advisory board includes pioneers in the plant-based foods industry, including HRH Prince Khaled bin Alwaleed bin Talal Al Saud, Founder and Chief Executive Officer of KBW Ventures, and Jeff Dunn, CEO of Bolthouse Farms who previously held senior leadership positions at both Campbell Soup Company and The Coca Cola Company. The company’s plant-based investment thesis is centered on growing its seed-to-market operations, which include raw ingredients, processing, pulse fractionation, unique IP and premium consumer packaged goods (CPG). Eat Well Group is building a unique ecosystem that can supply these essential cornerstone needs for society. The company has plant-based foods and nutrition experts specializing in the latest science and original thinking for what consumers want most – high quality and affordability in healthy, clean and simple products. Eat Well focuses on intellectual property, product portfolio development and long-term value creation for stakeholders in a rapidly expanding industry. As an emergent sector globally, plant-based foods represent a double-digit annual growth category, with more than 35% of the world’s supply of pulse proteins coming from Canada. Portfolio On July 31, 2021, Eat Well Group acquired Belle Pulses Ltd., one of the top pulse processors in Canada. Belle Pulses has been operating for over 40 years and had over $60 million in sales in 2020. The company counts a broad range of customers in over 35 countries, including global strategic food companies and major ingredient distributors. Currently, Belle produces nearly 100,000 tons of fully traceable seed and product, yielding over 26,000 tons of pure plant protein. Eat Well also owns 100% of Sapientia Technology Inc. Led by Dr. Eugenio Bortone – one of the world’s preeminent food scientists and extrusion processing experts and the inventor of Frito-Lay’s Twisted Cheetos – Sapientia has filed four patents around the “protein curl” and crispy-puff-style snack. By focusing on texture and crunch, Sapientia’s patents solve one of the major problems that large scale snack food companies have struggled with for years – how to offer appealing texture and flavor in a guilt-free, not fried, natural and healthy alternative to the majority of snack food products available today. Eat Well owns a 51% share of Amara Organic Foods, with an option to acquire additional ownership up to 80 percent. Amara, one of the fastest-growing baby food brands in America, is a food technology company that uses science and proprietary IP that locks in taste and texture to make healthy, organic, non-GMO, plant-based, convenient baby and children’s food possible for modern-day families. From baby food to toddler food and beyond, Amara is driven by the belief that setting kids on the right path from a young age will help them live better, feel better and think better for the rest of their lives. Amara’s revenues have grown by more than 400% since January 2021, and the brand’s success has drawn media coverage from business news outlets including Forbes and TechCrunch. Market Outlook According to an August 2021 report from Bloomberg Intelligence, the plant-based foods market is expected to experience explosive growth, comprising up to 7.7% of the global protein market by 2030 at a value of over $162 billion, up from $29.4 billion in 2020. Bloomberg notes that plant-based alternatives are here to stay, and that consumption will grow rapidly. Plant-based food sales in 2020 grew twice as fast as overall food sales, according to Polaris Market Research. Pulse proteins (fava, yellow pea, etc.) are a foundational ingredient to most plant-based foods due to their high protein content and their readily available, affordable supply. Many analysts view the food tech market as similar to the early days of the Internet in that plant-based foods represent a worldwide secular trend of steady growth and potential that will revolutionize the way society functions and people experience nutrition. The sector continues to experience significant M&A transactions. Recently, Sol Cuisine was acquired by PlantPlus Foods LLC, a major South American protein producer, in an all-cash transaction valued at approximately $126 million, or 6x revenue. Management Team Marc Aneed is President and Director of Eat Well Group. His 20-year career in CPG started at The Quaker Oats Company/PepsiCo, where he worked on iconic brands like Gatorade. He previously was at Glanbia PLC, a global nutrition company, where he led Amazing Grass, a leading plant nutrition and supplement company with over $100 million in retail sales. He also led Glanbia’s Sports Nutrition brands in North America with over $750 million in retail sales. Mr. Aneed has launched dozens of successful consumer products, driving over $1 billion in collective retail sales. Mark Coles is the company’s Chief Investment Officer. He is a veteran CPG senior executive specializing in the plant-based foods sector. For the past decade, Mr. Coles has spearheaded global plant-based start-up initiatives, culminating in a 2020 acquisition by an international New York Stock Exchange-listed food ingredient company. He has over 25 years of experience in CPG-focused strategy, mergers and acquisitions and project financing. Patrick Dunn is Eat Well Group’s Vice President, Finance. He is the founding partner of Dunn, Pariser & Peyrot and has a track record of building highly successful agribusinesses throughout North America and other international markets. As a testimony to his business portfolio work, Mr. Dunn and his firm have won multiple industry awards for accounting, finance and business management. Barry Didato is the company’s Vice President, Strategy. He is focused on the development of strategic revenue channels, sales partnerships, and international distribution for Eat Well Group. Mr. Didato brings extensive strategic sales capabilities and an extensive network of contacts in the industry to the company. Prior to joining Eat Well Group, he served for over 18 years as a senior advisor for several ultra-high net worth family offices and numerous innovative wellness, nutrition, medical, and food businesses. Strategic Advisory Board HRH Prince Khaled bin Alwaleed bin Talal Al Saud, Founder and Chief Executive Officer of KBW Ventures, is a firm supporter of clean energy and the humane treatment of animals. He is also a vocal supporter of the private sector in the Middle East. A member of the Saudi Arabian Royal Family, Prince Khaled was born in Stanford and spent his youth in Riyadh under the mentorship of his father, philanthropist HRH Prince Alwaleed bin Talal Al Saud, Chairman of Kingdom Holding Company. He is also the Founding Chairman of KBW Investments and serves across several boards. He invests in an array of successful but diverse global businesses – from promising technology startups to established companies. Today, with holdings on three continents, Prince Khaled stands at the gateway between the Middle East’s evolving economies and the Western world. Consistently, Prince Khaled’s focus is on ventures and ideas at the intersection of innovation and economic growth. Jeff Dunn has over 30 years of experience in agriculture and packaged food, including senior leadership positions with Bolthouse Farms, Campbell Soup Company and The Coca Cola Company, among others. He is an Operating Partner at Butterfly and focuses primarily on the agriculture & aquaculture and food & beverage product sectors. Prior to joining Butterfly, Mr. Dunn was the President of the Campbell Fresh division of Campbell Soup Company from 2015 to 2016, where he was in charge of building Campbell’s scale and accelerating its growth in the rapidly expanding packaged fresh segments and categories across the retail perimeter. For more information, visit the company’s website at www.EatWellGroup.com. NOTE TO INVESTORS: The latest news and updates relating to EWGFF are available in the company’s newsroom at https://ibn.fm/EWGFF

• DigiMax partners with BearClaw Esports to provide mutually beneficial collaboration
• Bitget partnership gives Cryptohawk users great opportunity to increase the efficiency and security of their trades
• DIGI join forces with prominent leader in the crypto industry in Asia

Powerful partnerships are key to a company’s success, and over the past six months, DigiMax Global (CSE: DIGI) (OTC: DBKSF) has built a portfolio of powerful partnerships, all designed to support the company’s strategic global efforts to unlock the potential of disruptive technologies by providing advanced financial, predictive and cryptocurrency solutions across various verticals. Last month, DigiMax announced a partnership with BearClaw Esports (https://ibn.fm/0h3UQ). The collaboration will give BearClaw’s community of streaming gamers and Esports followers access to DIGI’s CryptoHawk artificial intelligence (“AI”) products and information. “Esports gamers are well known for their affiliation with cryptocurrencies, with many gamers also using their computer hardware to mine and trade a wide variety of cryptocurrencies,” DIGI noted when announcing the partnership. “At $180 billion and growing by 20% in 2020, the video game category is now bigger than sports and movie revenue combined. . . . Gamers and crypto traders have a great deal in common, and most do both already and often on the same machines as more and more gamers are converting their gaming machines into miners in their spare time. Prior to its BearClaw announcement, DigiMax partnered with Singapore-based Bitget, a crypto exchange (https://ibn.fm/4WKBV). The agreement calls for DigiMax and Bitget to collaborate on mutually beneficial business arrangements, including allowing Btiget users to learn about DigiMax’s CryptoHawk and giving CryptoHawk direct access to Bitgets’ platform. “By partnering with Bitget, Cryptohawk users will have a great opportunity to increase the efficiency and security of their trades,” said DigiMax CEO Chris Carl. “But in the near future, they will have access to automated trading from Cryptohawk signals. We look forward to partnering with Bitget to deliver ever-increasing value to both our users now and in the future.” Earlier this year, DigiMax inked its first collaboration agreement to expand CryptoHawk services into Hong Kong and surrounding areas (https://ibn.fm/rRIt2). Based on the partnership agreement, DigiMax will collaborate with Tony Tong in Hong Kong and other Asian regions where he has substantial influence. According to the company, Tong is cochair and cofounder of the Hong Kong Blockchain Association, a council member of International Digital Asset Exchange Association and president of GlobalSTOx.io & APX.HK. The collaboration agreement between DigiMax and Tong includes the issuance of 200,000 common shares of DigiMax and an award of additional shares as he assists DigiMax in successfully completing partnering deals with exchanges or directly increasing the number of CryptoHawk subscribers in Asia. “We are excited to be able to join forces with Tony Tong who we respect as a prominent leader in the crypto industry in Asia,” said Carl. “Tony has been a leader and an innovator in every facet of the blockchain and crypto currency space, and we are certain that CryptoHawk can deliver a whole new level of value and power to anyone interested in trading or owning crypto currencies in their portfolio. DIGI’s powerful partnership portfolio is only one indication of the company’s commitment to produce and leverage predictive indicators across various industries and verticals as well as offer financial, business, and human capital AI predictive solutions to businesses, institutions and consumers. For more information, visit the company’s website at www.DigiMax-Global.com. NOTE TO INVESTORS: The latest news and updates relating to DBKSF are available in the company’s newsroom at https://ibn.fm/DBKSF